English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
欧康维视自研新药OT-101于中国完成完成受试者入组
Feb 01, 2023 10:02 HKT
歐康維視自研新藥OT-101於中國完成完成受試者入組
Feb 01, 2023 10:01 HKT
Ocumension Therapeutics Announces Its Patient Enrollment Completed In The Phase III Clinical Trail Of OT-101 In China
Feb 01, 2023 10:00 HKT
欧康维视生物分别任命阮添士先生及王冲先生为首席财务官及投资者关系负责人
Jan 30, 2023 11:40 HKT
歐康維視生物分別任命阮添士先生及王沖先生為首席財務官及投資者關係負責人
Jan 30, 2023 11:39 HKT
Ocumension Therapeutics Appoints Mr. Tim RUAN and Mr. WANG Chong as Chief Financial Officer and Head of Investor Relations respectively
Jan 30, 2023 11:38 HKT
Cantor Fitzgerald首次覆盖 普瑞健康予“增持”评级
Jan 26, 2023 12:21 HKT
Cantor Fitzgerald首次覆蓋 普瑞健康予“增持”評級
Jan 26, 2023 12:19 HKT
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating
Jan 26, 2023 12:16 HKT
医思健康料23财年第三季销售额按年升不少于8%
Jan 20, 2023 19:33 HKT
醫思健康料23財年第三季銷售額按年升不少於8%
Jan 20, 2023 19:32 HKT
EC Healthcare Expects Third Quarter FY23 Sales Volume to Increase no less than 8% YoY
Jan 20, 2023 19:31 HKT
中国最大的传统美容服务提供商美丽田园医疗健康于香港联合交易所主板挂牌
Jan 17, 2023 14:27 HKT
中國最大的傳統美容服務提供商美麗田園醫療健康於香港聯合交易所主板掛牌
Jan 17, 2023 14:26 HKT
BeautyFarm Med, the largest provider of traditional beauty services in China Successfully Listed on the Main Board of SEHK
Jan 17, 2023 14:25 HKT
美丽田园医疗健康公布全球发售结果 每股发售股份发售价为19.32港元
Jan 13, 2023 12:12 HKT
美麗田園醫療健康公佈全球發售結果 每股發售股份發售價為19.32港元
Jan 13, 2023 12:11 HKT
BeautyFarm Med Announces Global Offering Results, Offer Price of HK$19.32per Share
Jan 13, 2023 12:10 HKT
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
Jan 12, 2023 15:00 HKT
Novotech Acquires European CRO, Strengthens Global Operations
Jan 12, 2023 15:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: